KZRVA3TTT1

Opticap XLT30 Viresolve NFR 1-1/2 in. TC/TC

• Code UNSPSC : 23151806
• eCl@ss : 32031690

Propriétés

• Matériaux: polyethersulfone ; polypropylene ; polypropylene support; polypropylene vent cap; silicone seal
• Niveau de qualité: 400
• Description: T-line
• Paramètres: ≤48 mL/min air diffusion at 3.45 bar (50 psig) (in water); 25 °C max. inlet temp.; 3.4 bar max. differential pressure (50 psid) (Reverse); 5.5 bar max. differential pressure (80 psid) (Forward); 5.5 bar max. inlet pressure (80 psi) at 23 °C; 80 psig max. inlet pressure
• Technique(s): protein purification: suitable
• Longueur: 86 cm (34 in.)
• device size: 30 in.
• Surface de filtration: 1.281 m²
• Volume mort: 490 mL
• Diam. du raccord d'entrée: 1 1/2 in.
• outlet W: 15.2 cm (6.0 in.)
• Diam. du raccord de sortie: 1-1/2 in.
• Taille: 1800-3600 L
• Impuretés: ≤0.5 EU/mL Aqueous extraction (LAL test)
• Matrice: Viresolve^® NFR
• Raccords: 1/4 in. hose barb (double O-ring Seal); inlet sanitary flange; outlet sanitary flange; 38 mm (1 1/2 in.) sanitary flange drain/vent
• Adéquation: suitable for endotoxin

Description

Description générale

A sample aqueous extraction contains less than 0.5 EU/mL as determined by the Limulus Amebocyte Lysate (LAL) test.

After wetting, may be autoclaved for 3 cycles of up to 60 min at 125 °C, using liquid cycle, slow exhaust.

Conditionnement

Double Easy-Open bag

Remarque sur l'analyse

The extractables level was equal to or less than 105 mg after a 10 minute 1.5 LPM/ft² flush and 24 hours in water at controlled room temperature.

Will meet the USP Oxidizable Substances Test requirements after a water flush of ≥12 L

Informations légales

VIRESOLVE is a registered trademark of Merck KGaA, Darmstadt, Germany

Clause de non-responsabilité

These products are manufactured in a facility which adheres to FDA Good Manufacturing Practices.